liquidia-lqda-executive-sells-80k-shares-australia
As the Australian investment landscape continues to evolve, a recent move by a high-ranking executive at Liquidia, a biotechnology company, has raised eyebrows among investors and market watchers. The Chief Commercial Officer of Liquidia, responsible for driving the company’s commercial strategy, has sold 80,000 shares for a staggering $2.8 million. This significant transaction has sparked […]
liquidia-lqda-executive-sells-80k-shares-australia Read More »










